Abstract
Advanced practitioners are key members of the oncology care team, and their numbers and significance continue to expand. While the role of the AP has become well defined in everyday clinical practice, there is still space to define the AP role in clinical research. In accordance with its mission, the Advanced Practitioner Society for Hematology for Oncology (APSHO) recognizes the significance of addressing the role of the AP in clinical research. This article discusses three key projects related to APs and clinical research (a 2020 benchmarking survey, a 2021 summit, and a 2023 collaboration) and addresses how APSHO is working to continually support the AP role in clinical research through advocacy, committees, formal education, publications, and mentoring.
Advanced Practitioners in Hematology and Oncology: A Call to Action
Introduction
Advanced Practitioners in Hematology and Oncology: State of the Workforce
The Value of the Advanced Practitioner in Hematology and Oncology: Establishing Benchmarks
Understanding Advanced Practitioner Prescriptive Privileges for Anticancer Therapies: A National Survey
Advanced Practitioners as Agents of Change: Leveraging Quality Improvement to Improve Practice
Role of the Advanced Practitioner in Clinical Research
APSHO Oncology/Hematology Advanced Practitioner Compensation Survey
